Create 9:16 engaging, informative academic poster for pharmacetical conference based on the topic as well as finalised abstract. Topic- STOCKOUT-INDUCED REFILL GAP (SIRG) IN INDIAN PUBLIC-SECTOR CHRONIC CARE: A SYSTEMATIC SYNTHESIS OF CLINICAL-ECONOMIC CONSEQUENCES Abstract-Public-sector non-communicable disease (NCD) management in India relies on constrained 15-day dispensing cycles, producing recurrent facility-level stockouts and the Stockout-Induced Refill Gap (SIRG). While isolated components of this failure are documented - short dispensing durations and 'drug holidays' and national stockout-adherence-OOP associations- no study has unified them into one quantified clinical-economic pathway. This integrative review synthesizes public health registries, community NCD cohort data (N=2,840), and tertiary care surveys across four Indian states to model SIRG as a sequential cascade: stockout → missed refill → pharmacokinetic decay → complication onset → catastrophic expenditure. In public facilities, 51.7% of chronic care patients incur out-of-pocket (OOP) drug costs due to stockouts; 71.2% miss scheduled refills from travel/financial burden, and 18.4% fail to replenish medication entirely. Diabetic OOP spend reaches INR 671.77 of INR 1,522.27 monthly; urban slum cohorts report INR 2,200 median monthly spend, driving 39.44% Catastrophic Health Expenditure (CHE). Unresolved SIRG episodes escalate monthly outpatient cost by INR 525 and shift patients toward private inpatient care costing 7.6× public rates (INR 50,508 vs INR 6,631), pushing 21% of affected households into distress financing. We estimate a single unresolved SIRG episode raises expected patient cost by 23x to 30x, a metric absent from existing literature. Transitioning to 90-day dispensing - aligned with WHO's 2023 Global Hypertension Report - could avert this cascade, saving INR 160 per visit in transport costs while decongesting facilities and protecting households from medical impoverishment.
Create 9:16 engaging, informative academic poster for pharmacetical conference based on the topic as well as finalised abstract.
Topic- STOCKOUT-INDUCED REFILL GAP (SIRG) IN INDIAN PUBLIC-SECTOR CHRONIC CARE: A SYSTEMATIC SYNTHESIS OF CLINICAL-ECONOMIC CONSEQUENCES
Abstract-Public-sector non-communicable disease (NCD) management in India relies on constrained 15-day dispensing cycles, producing recurrent facility-level stockouts and the Stockout-Induced Refill Gap (SIRG). While isolated components of this failure are documented - short dispensing durations and 'drug holidays' and national stockout-adherence-OOP associations- no study has unified them into one quantified clinical-economic pathway. This integrative review synthesizes public health registries, community NCD cohort data (N=2,840), and tertiary care surveys across four Indian states to model SIRG as a sequential cascade: stockout → missed refill → pharmacokinetic decay → complication onset → catastrophic expenditure. In public facilities, 51.7% of chronic care patients incur out-of-pocket (OOP) drug costs due to stockouts; 71.2% miss scheduled refills from travel/financial burden, and 18.4% fail to replenish medication entirely. Diabetic OOP spend reaches INR 671.77 of INR 1,522.27 monthly; urban slum cohorts report INR 2,200 median monthly spend, driving 39.44% Catastrophic Health Expenditure (CHE). Unresolved SIRG episodes escalate monthly outpatient cost by INR 525 and shift patients toward private inpatient care costing 7.6× public rates (INR 50,508 vs INR 6,631), pushing 21% of affected households into distress financing. We estimate a single unresolved SIRG episode raises expected patient cost by 23x to 30x, a metric absent from existing literature. Transitioning to 90-day dispensing - aligned with WHO's 2023 Global Hypertension Report - could avert this cascade, saving INR 160 per visit in transport costs while decongesting facilities and protecting households from medical impoverishment.
Created using ChatSlide
The SIRG Cascade project highlights the clinical and economic burdens caused by stockouts, emphasizing the need to quantify out-of-pocket expenses and complication risks within an Indian cohort. Meanwhile, the 90-Day Dispensing initiative presents a decision case for publication, modeling significant cost escalations and projecting substantial savings while aiming to improve refill continuity and system efficiency.